FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011897098> ?p ?o ?g. }

• W2011897098 endingPage "190" @default.
• W2011897098 startingPage "190" @default.
• W2011897098 abstract "Triple anti-platelet therapy is known to prevent restenosis after drug-eluting stent (DES) implantation. However, there is little available data concerning the efficacy of triple anti-platelet therapy for acute myocardial infarction (AMI).We analyzed 528 consecutive patients with AMI undergoing DES implantation between Nov 2005 and Apr 2008. We compared clinical outcomes in the triple anti-platelet therapy (group I, n=413: cilostazol combined with aspirin and clopidogrel for at least one month) and dual antiplatelet therapy groups (group II, n=115: aspirin and clopidogrel).There were no significant differences in baseline characteristics. However, ST elevation myocardial infarction (STEMI) and use of TAXUS(R) stents were more common (70.9% vs. 55.7%, p=0.002; 83.5% vs. 73.0%, p=0.011) in Group I. Group I had lower incidences of cardiac death, 6-month target lesion revascularization (TLR), and major adverse cardiac and cerebrovascular events (MACCE) compared to Group II (1.7% vs. 5.7%, p=0.022; 5.7% vs. 11.5%, 0.035; 7.9% vs. 16.0%, p=0.011). On subgroup analysis, the incidence of 6-month TLR was lower among patients with American College of Cardiology/American Heart Association (ACC/AHA) B2 or C lesions and non-STEMI (6.0% vs. 14.9%, p=0.012; 4.3% vs. 19.1%, p=0.002) in Group I compared to those in Group II. The rates of bleeding complications were no different between the two groups. On multivariate analysis, Killip III or IV and triple anti-platelet therapy were independent predictors of 6-month MACCE {hazard ratio (HR)=3.382; 95% confidence interval (CI)=1.384-8.262, HR=0.436; 95% CI=0.203-0.933}.Triple anti-platelet therapy is safe and efficacious, and it prevents TLR in patients with AMI, especially those with complex lesions and non-STEMIs." @default.
• W2011897098 created "2016-06-24" @default.
• W2011897098 creator A5007959162 @default.
• W2011897098 creator A5013429451 @default.
• W2011897098 creator A5028006741 @default.
• W2011897098 creator A5029628880 @default.
• W2011897098 creator A5034176785 @default.
• W2011897098 creator A5034274166 @default.
• W2011897098 creator A5035456738 @default.
• W2011897098 creator A5045594197 @default.
• W2011897098 creator A5048695610 @default.
• W2011897098 creator A5052825841 @default.
• W2011897098 creator A5053728368 @default.
• W2011897098 creator A5061574546 @default.
• W2011897098 creator A5070668206 @default.
• W2011897098 creator A5070988147 @default.
• W2011897098 creator A5074893722 @default.
• W2011897098 creator A5079142386 @default.
• W2011897098 date "2009-01-01" @default.
• W2011897098 modified "2023-09-26" @default.
• W2011897098 title "Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation" @default.
• W2011897098 cites W1553345686 @default.
• W2011897098 cites W1977072761 @default.
• W2011897098 cites W1977736221 @default.
• W2011897098 cites W1981589156 @default.
• W2011897098 cites W1998792752 @default.
• W2011897098 cites W2005060973 @default.
• W2011897098 cites W2010125177 @default.
• W2011897098 cites W2010354322 @default.
• W2011897098 cites W2015710474 @default.
• W2011897098 cites W2030849154 @default.
• W2011897098 cites W2031787382 @default.
• W2011897098 cites W2041988871 @default.
• W2011897098 cites W2045245494 @default.
• W2011897098 cites W2049120615 @default.
• W2011897098 cites W2054378052 @default.
• W2011897098 cites W2057218988 @default.
• W2011897098 cites W207590421 @default.
• W2011897098 cites W2079917183 @default.
• W2011897098 cites W2084673482 @default.
• W2011897098 cites W2085869089 @default.
• W2011897098 cites W2092792529 @default.
• W2011897098 cites W2094951506 @default.
• W2011897098 cites W2095595561 @default.
• W2011897098 cites W2100113253 @default.
• W2011897098 cites W2104660435 @default.
• W2011897098 cites W2112995033 @default.
• W2011897098 cites W2119380659 @default.
• W2011897098 cites W2141021889 @default.
• W2011897098 cites W2616526627 @default.
• W2011897098 cites W4376848313 @default.
• W2011897098 doi "https://doi.org/10.4070/kcj.2009.39.5.190" @default.
• W2011897098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2771786" @default.
• W2011897098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19949578" @default.
• W2011897098 hasPublicationYear "2009" @default.
• W2011897098 type Work @default.
• W2011897098 sameAs 2011897098 @default.
• W2011897098 citedByCount "9" @default.
• W2011897098 countsByYear W20118970982012 @default.
• W2011897098 countsByYear W20118970982013 @default.
• W2011897098 countsByYear W20118970982017 @default.
• W2011897098 countsByYear W20118970982021 @default.
• W2011897098 crossrefType "journal-article" @default.
• W2011897098 hasAuthorship W2011897098A5007959162 @default.
• W2011897098 hasAuthorship W2011897098A5013429451 @default.
• W2011897098 hasAuthorship W2011897098A5028006741 @default.
• W2011897098 hasAuthorship W2011897098A5029628880 @default.
• W2011897098 hasAuthorship W2011897098A5034176785 @default.
• W2011897098 hasAuthorship W2011897098A5034274166 @default.
• W2011897098 hasAuthorship W2011897098A5035456738 @default.
• W2011897098 hasAuthorship W2011897098A5045594197 @default.
• W2011897098 hasAuthorship W2011897098A5048695610 @default.
• W2011897098 hasAuthorship W2011897098A5052825841 @default.
• W2011897098 hasAuthorship W2011897098A5053728368 @default.
• W2011897098 hasAuthorship W2011897098A5061574546 @default.
• W2011897098 hasAuthorship W2011897098A5070668206 @default.
• W2011897098 hasAuthorship W2011897098A5070988147 @default.
• W2011897098 hasAuthorship W2011897098A5074893722 @default.
• W2011897098 hasAuthorship W2011897098A5079142386 @default.
• W2011897098 hasBestOaLocation W20118970982 @default.
• W2011897098 hasConcept C126322002 @default.
• W2011897098 hasConcept C164705383 @default.
• W2011897098 hasConcept C2777546689 @default.
• W2011897098 hasConcept C2777628954 @default.
• W2011897098 hasConcept C2777698277 @default.
• W2011897098 hasConcept C2777849778 @default.
• W2011897098 hasConcept C2778283817 @default.
• W2011897098 hasConcept C2778583881 @default.
• W2011897098 hasConcept C2779820409 @default.
• W2011897098 hasConcept C2780400711 @default.
• W2011897098 hasConcept C500558357 @default.
• W2011897098 hasConcept C71924100 @default.
• W2011897098 hasConceptScore W2011897098C126322002 @default.
• W2011897098 hasConceptScore W2011897098C164705383 @default.
• W2011897098 hasConceptScore W2011897098C2777546689 @default.
• W2011897098 hasConceptScore W2011897098C2777628954 @default.
• W2011897098 hasConceptScore W2011897098C2777698277 @default.
• W2011897098 hasConceptScore W2011897098C2777849778 @default.

• next